日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Innovation

Chinese scientists develop innovative molecule for precision cancer treatment

Xinhua | Updated: 2026-01-09 10:45
Share
Share - WeChat

SHENZHEN -- Chinese researchers have developed an innovative "intratumoral vaccine" molecule that prevents cancer cells from suppressing immune function while redirecting the body's pre-existing immune memory to attack tumors — offering a novel approach for cancer treatment.

Scientists from Shenzhen Bay Laboratory and Peking University reported the findings in a study published online in the journal Nature on Thursday.

Although immune checkpoint blockade therapy has transformed cancer treatment by enhancing the immune system's ability to target tumors, it remains ineffective for many patients. A primary reason is that due to low mutational burden and a consequent paucity of neoantigens, malignant cells in many patients evade immune system recognition.

The research team turned to a largely untapped immune resource known as "bystander T cells." Generated in response to prior infections such as cytomegalovirus (CMV), these T cells remain dormant yet retain immunological memory in most adults. The researchers proposed that if tumors could be made to display CMV antigens, these abundant memory T cells could be mobilized against the cancer.

To realize this, the team designed a synthetic molecule called an "intratumoral vaccination chimera" (iVAC). This dual-function molecule irreversibly targets and degrades PD-L1 protein on tumor cells — effectively releasing the immune system's brakes — while also delivering a CMV antigen epitope. By marking tumors with this viral signature, iVAC redirects the body's reservoir of anti-CMV T cells to recognize and eliminate cancer cells.

In both mouse models and patient-derived tumor clusters, iVAC successfully activated T cells and exhibited strong anti-tumor activity. The results demonstrate the potential of harnessing the immune system's memory against common viruses for cancer therapy.

The researchers are now developing translational molecules based on the mechanism in the study and aim to progress this technology toward future clinical trials, said Chen Peng, a senior investigator from Shenzhen Bay Laboratory.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 婷婷久久综合 | 久久久一区二区三区 | 欧美成人一区二区三区片免费 | 亚洲天堂精品在线 | 狠狠操综合网 | 99热国产在线 | 久久精品这里只有精品 | 久久久免费高清视频 | 国产传媒在线播放 | 日日骚| 91福利免费视频 | 日韩国产欧美视频 | 爱爱一区二区三区 | 在线播放日韩av | 国产999精品久久久久久 | 久久久久免费视频 | 免费毛片大全 | 黄色三级a | 四虎影院久久 | 色站综合| 最新高清无码专区 | 国产视频欧美 | 欧美日韩视频网站 | 精品成人在线 | 91tv国产成人福利 | 黄色网久久 | 午夜精品在线 | 日韩在线综合 | 色妞色视频一区二区三区四区 | 亚洲系列在线观看 | 91午夜剧场 | h片在线观看 | 在线观看国产精品视频 | 丁香婷婷网 | 自拍偷拍欧美视频 | 黄色片成年人 | 一区二区免费在线观看 | 亚洲色图综合网 | 欧美亚洲二区 | 蜜桃成人免费视频 | 天堂中文字幕在线观看 |